Stellar Biotechnologies Announces Pricing of $6.75 Million Registered Direct Offering
PORT HUENEME, CA -- (Marketwired) -- 06/30/16 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), announced today that it …